Please use this identifier to cite or link to this item:
Title: Outcomes of Percutaneous Coronary Intervention in Patients with Rheumatoid Arthritis.
Austin Authors: Dawson, Luke P;Dinh, Diem;O'Brien, Jessica;Duffy, Stephen J;Guymer, Emma;Brennan, Angela;Clark, David J ;Oqueli, Ernesto;Hiew, Chin;Freeman, Melanie;Reid, Christopher M;Ajani, Andrew E
Affiliation: Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia
Department of Rheumatology, Monash Medical Centre, Melbourne, Victoria, Australia
Department of Medicine, Melbourne University, Victoria, Australia
Department of Medicine, Monash University, Melbourne, Victoria, Australia
Centre of Cardiovascular Research and Education in Therapeutics, Monash University, Melbourne, Victoria, Australia
Department of Cardiology, Box Hill Hospital, Melbourne, Victoria, Australia
Department of Cardiology, University Hospital, Geelong, Victoria, Australia
Department of Cardiology, Royal Melbourne Hospital, Melbourne, Victoria, Australia
Department of Cardiology, Ballarat Health Services, Ballarat, Victoria, Australia
School of Medicine, Faculty of Health, Deakin University, Geelong, Victoria, Australia
Department of Cardiology, The Alfred Hospital, Melbourne, Victoria, Australia
Issue Date: 1-Feb-2021
Date: 2020-10-31
Publication information: The American Journal of Cardiology 2021; 140: 39-46
Abstract: RA is the most common inflammatory arthritis and is associated with increased risk of cardiovascular events and mortality. Evidence regarding outcomes following PCI is limited. This study aimed to assess differences in outcomes following percutaneous coronary intervention (PCI) between patients with and without rheumatoid arthritis (RA). The Melbourne Interventional Group PCI registry (2005-2018) was used to identify 756 patients with RA. Outcomes were compared to the remaining cohort (N=38,579). Patients with RA were older, more often female, with higher rates of hypertension, previous stroke, peripheral vascular disease, obstructive sleep apnoea, chronic lung disease, myocardial infarction, and renal impairment, while rates of dyslipidaemia and current smoking were lower, all p<0.05. Lesions in patients with RA were more frequently complex (ACC/AHA type B2/C), requiring longer stents, with higher rates of no reflow, all p<0.05. Risk of long-term mortality, adjusted for potential confounders, was higher for patients with RA (Hazard Ratio 1.53, 95%CI 1.30-1.80; median follow-up 5.0 years), while 30-day outcomes including mortality, major adverse cardiovascular events, bleeding, stroke, myocardial infarction, coronary artery bypass surgery and target vessel revascularisation were similar. In subgroup analysis, patients with RA and lower BMI (Pfor interaction<0.001) and/or acute coronary syndromes (Pfor interaction=0.05) had disproportionately higher risk of long-term mortality compared to patients without RA. In conclusion, patients with RA undergoing PCI had more comorbidities and longer, complex coronary lesions. Risk of short-term adverse outcomes were similar, while risk of long-term mortality was higher, especially among patients with acute coronary syndromes and lower BMI.
DOI: 10.1016/j.amjcard.2020.10.048
Journal: The American Journal of Cardiology
PubMed URL: 33144158
Type: Journal Article
Subjects: cardiovascular disease
percutaneous coronary intervention
rheumatoid arthritis
risk factors
systemic inflammation
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Dec 5, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.